R

REPLIGEN CORP

RGEN Nasdaq Healthcare · Biological Products, (No Diagnostic Substances) Waltham, MA www.repligen.com
$181.62
Mkt Cap 10.25B
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$785.1M
15% CAGR
FCF TTM
$110.8M
14.1% margin
P/E RATIO
246.8x
—
P/FCF
92.5x
—
Running full 6-factor analysis…